Location: Germany
Mentions in press and media 6
| Date | Title | Description |
| 07.04.2026 | +++ Kopexa +++ 14leafs +++ Taxfix +++ Cellbricks +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Dienstag, 7. April). #STARTUPLAND STARTUPLAND: Founders. VCs. Visionaries +++ Am 10. März 2027 findet im Rhe... |
| 27.03.2026 | European Deep Tech Attracts Mega Capital: AI, Robotics, Biotech, and Climate Solutions Secure Major Funding | European startups attract massive capital. Kandou AI leads with $225 million for AI infrastructure connectivity, breaking memory bottlenecks. Interloom secured $16.5 million for business automation software. Kewazo raised $15 million to rev... |
| 27.03.2026 | Cellbricks Accelerates Organ Printing Vision with €10M Funding | Cellbricks Therapeutics secured €10M. This capital propels their biofabricated human tissue implants. The Berlin-Boston biotech firm revolutionizes regenerative medicine. Their proprietary light-based bioprinting platform creates vasculariz... |
| 26.03.2026 | Cellbricks Therapeutics Raises €10M in Funding | Cellbriks Therapeutics, a Berlin, Germany- and Boston, MA-based tissue engineering company, raised approx. $10M in funding, including a €7M Seed round and more than €3M in additional non-dilutive funding currently under negotiation. The rou... |
| 25.03.2026 | Kandou AI bekommt 225 Millionen – Interloom sammelt 16,5 Millionen ein – Kewazo streicht 15 Millionen ein | Im #DealMonitor für den 25. März werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor-Arc... |
| 25.03.2026 | Building the path to 3D-printed organs, Cellbricks raises €10M for biofabricated tissue implants | Berlin-founded biotech startup Cellbricks Therapeutics has raised €10 million to advance its goal of 3D-printed organs, beginning with biofabricated human tissue implants. If successful, Cellbricks is not just building better implants — it ... |